Klaus Beiske Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Quantification of bone marrow disease in high risk neuroblastoma patients by anti-GD2 immunocytochemistry – impact on survival. A SIOPEN High Risk Study. — Poster Session 1 with wine & cheese